Related Experiment Video

Updated: Apr 3, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.9K

Down-regulation of SOSTDC1 promotes thyroid cancer cell proliferation via regulating cyclin A2 and cyclin E2

Weiwei Liang1, Hongyu Guan1, Xiaoying He1

  • 1Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

Oncotarget
|September 18, 2015
PubMed

Insights

Sclerostin domain containing protein 1 (SOSTDC1) is reduced in thyroid cancer, acting as a tumor suppressor. Overexpressing SOSTDC1 inhibits cancer cell growth and may offer a new therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Sclerostin domain containing protein 1 (SOSTDC1) is recognized for its tumor-suppressive roles in various cancers.
  • The specific role and expression of SOSTDC1 in thyroid cancer remain largely uncharacterized.

Purpose of the Study:

  • To investigate the expression levels of SOSTDC1 in thyroid cancer.
  • To elucidate the biological functions and therapeutic potential of SOSTDC1 in thyroid cancer.

Main Methods:

  • Quantitative analysis of SOSTDC1 expression in thyroid cancer tissues.
  • In vitro studies involving ectopic SOSTDC1 overexpression in thyroid cancer cell lines.
  • In vivo tumor xenograft models in nude mice to assess SOSTDC1's effect on tumor growth.
  • Analysis of cell cycle regulatory proteins, including cyclin A2 and cyclin E2.

Main Results:

  • SOSTDC1 expression was significantly downregulated in thyroid cancer tissues compared to normal tissues.
  • Ectopic SOSTDC1 overexpression inhibited thyroid cancer cell proliferation and induced G1/S phase cell cycle arrest.
  • Overexpression of SOSTDC1 suppressed tumor growth in vivo.
  • SOSTDC1 overexpression led to the inhibition of cyclin A2 and cyclin E2 expression.

Conclusions:

  • SOSTDC1 is downregulated in thyroid cancer, indicating its role as a potential tumor suppressor.
  • SOSTDC1 exhibits anti-proliferative effects and can induce cell cycle arrest in thyroid cancer.
  • SOSTDC1 represents a promising therapeutic target for thyroid cancer treatment.
Keywords:
SOSTDC1cyclin A2cyclin E2proliferationthyroid cancer

More Related Videos

Induction and Analysis of Epithelial to Mesenchymal Transition10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

36.7K
Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

28.7K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
9.0K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.1K